Combined Research

 
Stock Quotes for Combined Research top ^
  • Industry: Rubber & Plastics
  • Sector: Consumer Cyclical
  • Stock Style: Small Value
Sign-up for n0z investment picks

 
News Articles for Combined Research top ^
2015/1/5
NEW YORK , Jan.
Sign-up for Chart Acquisition Corp. Agrees To Business Combination With Tempus Applied Solutions, LLC investment picks
2015/2/11
Combined Company renamed "Dawson Geophysical Company" and to continue trading on NASDAQ under "DWSN" MIDLAND, Texas , Feb.
Sign-up for Dawson Geophysical Announces Completion Of Strategic Business Combination investment picks
2015/1/27
ACE Limited (NYSE: ACE) today reported net income for the quarter ended December 31, 2014, of $1.66 per share, compared with $2.90 per share for the same quarter last year.
Sign-up for ACE Reports Fourth Quarter Operating Income of $827 Million and Record Full-Year Earnings of $3.3 Billion, Up 4.7% per Share; Operating ROE of 11.8% for the Quarter and 12% for the Year; Full-Year P&C Combined Ratio of 87.7% versus 88% Last Year investment picks
2015/2/23
HOUSTON, Feb.
Sign-up for Hennessy Capital Receives Stockholder Approval of Blue Bird Business Combination investment picks
2015/1/22
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1170694&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA and WEST PALM BEACH, FL --
Sign-up for CollabRx and Medytox Solutions Sign Non-Binding Letter of Intent for Possible Business Combination investment picks
2015/1/22
SAN FRANCISCO and WEST PALM BEACH, Fla., Jan.
Sign-up for CollabRx and Medytox Solutions Sign Non-Binding Letter of Intent for Possible Business Combination investment picks
2015/2/2
The Combined Company Will Trade on the NYSE With a New Ticker Symbol of GEN KENNETT SQUARE, Pa.
Sign-up for Genesis Healthcare Combines With Skilled Healthcare Group, Inc. investment picks
2015/2/25
SiriusXM listeners to get insider tips on early-stage startups and the technology industry from one of the nation's most prestigious startup accelerators, hosted by Y Combinator partner Aaron Harris NEW YORK , Feb.
Sign-up for SiriusXM to Launch "Startup School Radio" with Y Combinator Partner Aaron Harris investment picks
2015/1/26
Please replace the release with the following corrected version due to multiple revisions.
Sign-up for CORRECTING and REPLACING HASBRO Invites TRANSFORMERS Fans to Create Massive Transformer Character to Enlist in the COMBINER WARS investment picks
2014/12/22
http://media3.marketwire.com/logos/20140725-OSK_logo_200.jpg http://www.ccnmatthews.com/logos2/virginia.jpg MONTREAL, QUEBEC and QUEBEC CITY, QUEBEC --
Sign-up for ISS Recommends That Osisko and Virginia Shareholders Vote FOR the Business Combination investment picks
2015/1/6
Majority of the Holders of the Currently Outstanding Kitara Common Stock Have Previously Agreed to Vote in Favor of Proposed Business Combination JERSEY CITY, N.J. , Jan.
Sign-up for Kitara Media Corp. Adjourns Special Meeting of Stockholders Relating to Proposed Business Combination to Allow SEC to Complete Review of Proxy Statement investment picks
2015/1/16
- Majority of the Holders of the Currently Outstanding Kitara Common Stock Have Previously Agreed to Vote in Favor of Proposed Business Combination JERSEY CITY, N.J. , Jan.
Sign-up for Kitara Media Corp. Adjourns Special Meeting of Stockholders Relating to Proposed Business Combination to January 26, 2015 and Anticipates Consummating Merger with Future Ads Shortly Thereafter investment picks
2015/2/23
Creates a Global Leader in Fast-Growing Silicon and Specialty Metals Industry Creates Diversified Global Player Positioned for Growth with Broader Product Offering Strong Balance Sheet, Lower Costs and Greater Geographic Reach Better Able to Serve Customers in Rapidly Growing End Markets Transaction Expected to Generate Substantial Synergies Accretive to Globe Specialty Metals Shareholders on an Earnings per Share Basis in the First Year Globe Specialty Metals and Grupo FerroAtlántica Management to Host Conference Call Today at 8:30 a.m. Eastern Time MADRID and MIAMI , Feb.
Sign-up for Grupo FerroAtlántica And Globe Specialty Metals Agree To $3.1 Billion Combination investment picks
2015/2/9
http://media.marketwire.com/attachments/201502/83944_BlueNRGYlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1174179&ProfileId=051205&sourceType=1 SYDNEY, AUSTRALIA --
Sign-up for CBD Energy Limited and BlueNRGY LLC Combine investment picks
2014/12/9
100% of evaluable CLL/SLL patients (9/9) had nodal reductions, with 6 of 9 patients achieving a PR with the remaining 3 patients on study with nodal reductions ranging from 15% to 45% and a peripheral response (normalization or >50% decrease in ALC) pending additional assessments 83% (5/6) of patients with Non-Hodgkin's Lymphoma; 3/3 DLBCL and 2/3 Follicular Lymphoma (FL) responded to the combination at the highest dose tested, including 2 CR's in patients with DLBCL confirmed by independent review Collectively, 87 patients have been treated with TGR-1202, alone or in combination with TG-1101, without the observance of drug-related hepatic toxicity Dose escalation continues with TGR-1202 at 800mg micronized The combination of TG-1101, TGR-1202, and ibrutinib ("Triple Therapy") was safely administered to 5 patients with heavily pre-treated NHL, CLL, and Richter's transformation with no dose limiting toxicities observed, and no Grade 3 or 4 events observed to
Sign-up for Preliminary Data From Ongoing Phase I/II Dose Escalation Study of TG-1101 (Ublituximab) in Combination With TGR-1202 in Heavily Pre-treated Relapsed/Refractory B-Cell Malignancies Demonstrates Encouraging Clinical Activity and Safety investment picks
2014/12/31
http://media3.marketwire.com/logos/20140725-OSK_logo_200.jpg http://www.ccnmatthews.com/logos2/virginia.jpg MONTREAL, QUEBEC and QUEBEC CITY, QUEBEC --
Sign-up for Glass Lewis and ISS Recommend That Osisko and Virginia Shareholders Vote for the Business Combination investment picks
2015/1/20
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced dosing of the first patient in a new clinical trial evaluating the combination of VS-5584, its dual mTORC1/2 and PI3K inhibitor, in combination with VS-6063, the Company’s lead focal adhesion kinase (FAK) inhibitor, in patients with relapsed mesothelioma.
Sign-up for Verastem Doses First Patient in Phase 1 Clinical Trial Evaluating VS-5584 in Combination with VS-6063 in Mesothelioma investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Combined Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Combined Ratio  |  Next: Comerica Bank